New + Emerging Treatments
The New + Emerging Treatments conference is hosted by the Leukemia Research Foundation for leukemia patients, caregivers, family members, and healthcare professionals. Each hour-long webinar is dedicated to a specific subtype of leukemia, discussing the latest treatments and what's on the horizon, followed by a Q + A.
The virtual conference programs are Tuesday, June 11 and Wednesday, June 12. Participants can register for one or multiple sessions.
Chronic lymphocytic leukemia (CLL)
Tuesday, June11, 2024 i 7:00PM-8:00PM CT (5-6 PT, 6-7 MT, 8-9 ET)
Farrukh T. Awan, MD, from the Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, will discuss current CLL treatments and what new treatments are on the horizon.
Chronic myeloid leukemia (CML)
TUESDAY, JUNE 11, 2024 I 8:00-9:00 CT (6-7 PT, 7-8 MT, 9-10 ET)
Gabriela Hobbs, MD, Clinical Director of the Adult Leukemia Service Program, from Massachusetts General Hospital, will discuss current CML treatments and what new treatments are on the horizon.
Wednesday, JUNE 12, 2024 I 7:00-8:00PM CT (5-6 PT, 6-7 MT, 8-9 ET)
Shira N. Dinner, MD, from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Feinberg School of Medicine, will discuss current ALL treatments and what new treatments are on the horizon.
Acute myeloid leukemia (AML)
Wednesday, June 12, 2024 | 8:00-9:00pm CT (6-7 PT, 7-8 MT, 9-10 ET)
Matt Christopher, MD, PhD, from the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, will discuss current AML treatments and what new treatments are on the horizon.
Program supporters
